820 related articles for article (PubMed ID: 20415480)
1. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.
Wadas TJ; Wong EH; Weisman GR; Anderson CJ
Chem Rev; 2010 May; 110(5):2858-902. PubMed ID: 20415480
[No Abstract] [Full Text] [Related]
2. The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.
Ikotun OF; Lapi SE
Future Med Chem; 2011 Apr; 3(5):599-621. PubMed ID: 21526898
[TBL] [Abstract][Full Text] [Related]
3. On-cartridge preparation and evaluation of
Socan A; Petrik M; Kolenc Peitl P; Krošelj M; Rangger C; Novy Z; Svajger U; Gmeiner T; Decristoforo C
Nucl Med Biol; 2019 Apr; 71():23-31. PubMed ID: 31128475
[TBL] [Abstract][Full Text] [Related]
4. Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects.
Pandey MK; DeGrado TR
Curr Radiopharm; 2021; 14(4):325-339. PubMed ID: 32867656
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.
Liu S
Adv Drug Deliv Rev; 2008 Sep; 60(12):1347-70. PubMed ID: 18538888
[TBL] [Abstract][Full Text] [Related]
6. Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y.
Soderlund AT; Chaal J; Tjio G; Totman JJ; Conti M; Townsend DW
J Nucl Med; 2015 Aug; 56(8):1285-91. PubMed ID: 26135111
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
Mansi R; Wang X; Forrer F; Kneifel S; Tamma ML; Waser B; Cescato R; Reubi JC; Maecke HR
Clin Cancer Res; 2009 Aug; 15(16):5240-9. PubMed ID: 19671861
[TBL] [Abstract][Full Text] [Related]
8. The production of [124I]iodine and [86Y]yttrium.
Schmitz J
Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1():S4-9. PubMed ID: 21484376
[TBL] [Abstract][Full Text] [Related]
9. Selection of the optimal macrocyclic chelators for labeling with
von Witting E; Garousi J; Lindbo S; Vorobyeva A; Altai M; Oroujeni M; Mitran B; Orlova A; Hober S; Tolmachev V
Eur J Pharm Biopharm; 2019 Jul; 140():109-120. PubMed ID: 31082509
[TBL] [Abstract][Full Text] [Related]
10. [PET radiopharmaceuticals: novelties and new possibilities].
Környei J; Mikecz P; Tóth G
Magy Onkol; 2014 Dec; 58(4):245-50. PubMed ID: 25517442
[TBL] [Abstract][Full Text] [Related]
11. The next generation of positron emission tomography radiopharmaceuticals in oncology.
Rice SL; Roney CA; Daumar P; Lewis JS
Semin Nucl Med; 2011 Jul; 41(4):265-82. PubMed ID: 21624561
[TBL] [Abstract][Full Text] [Related]
12. Molecular nuclear imaging: the radiopharmaceuticals (review).
Imam SK
Cancer Biother Radiopharm; 2005 Apr; 20(2):163-72. PubMed ID: 15869450
[TBL] [Abstract][Full Text] [Related]
13. Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging.
Vivier D; Sharma SK; Zeglis BM
J Labelled Comp Radiopharm; 2018 Jul; 61(9):672-692. PubMed ID: 29665104
[TBL] [Abstract][Full Text] [Related]
14. Hybrid Metal-Phenol Nanoparticles with Polydopamine-like Coating for PET/SPECT/CT Imaging.
Suárez-García S; Esposito TVF; Neufeld-Peters J; Bergamo M; Yang H; Saatchi K; Schaffer P; Häfeli UO; Ruiz-Molina D; Rodríguez-Rodríguez C; Novio F
ACS Appl Mater Interfaces; 2021 Mar; 13(9):10705-10718. PubMed ID: 33635046
[TBL] [Abstract][Full Text] [Related]
15. Copper-64 labeled nanoparticles for positron emission tomography imaging: a review of the recent literature.
Capriotti G; Varani M; Lauri C; Franchi G; Pizzichini P; Signore A
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):346-355. PubMed ID: 33073558
[TBL] [Abstract][Full Text] [Related]
16. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18 and Radiometal Labeling of Biomolecules via Disulfide Rebridging.
Richard M; Martin Aubert S; Denis C; Dubois S; Nozach H; Truillet C; Kuhnast B
Bioconjug Chem; 2023 Nov; 34(11):2123-2132. PubMed ID: 37881943
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
[TBL] [Abstract][Full Text] [Related]
19. Imaging Somatostatin Positive Tumors with Tyr
Noor A; Van Zuylekom JK; Rudd SE; Roselt PD; Haskali MB; Yan E; Wheatcroft M; Hicks RJ; Cullinane C; Donnelly PS
Bioconjug Chem; 2021 Jul; 32(7):1192-1203. PubMed ID: 33788556
[TBL] [Abstract][Full Text] [Related]
20. Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging.
Pecking AP; Bellet D; Alberini JL
Clin Exp Metastasis; 2012 Oct; 29(7):847-52. PubMed ID: 22760521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
